Identity
- Trade Name
- Trabectome I/A Console (110V) FDA UDI
- Generic Name
- Ophthalmic irrigation/aspiration pump FDA UDI
- Device Name
- The Trabectome I/A Console (110V) is an aspiration pump intended for use in general surgery applications where aspiration of irrigation waste and waste fluid is desired. FDA UDI
- Model / Reference
- 550014 FDA UDI
- Description
- The Trabectome I/A Console (110V) is an aspiration pump intended for use in general surgery applications where aspiration of irrigation waste and waste fluid is desired. FDA UDI
Identifiers
- Catalog Number
- 550014-01 FDA UDI
- Primary DI / UDI-DI
- 00854028002023 FDA UDI
- FDA Product Code
- BTA FDA UDI
- GMDN Term
- Ophthalmic irrigation/aspiration pump FDA UDI
Classification
- Device Class
- Class II FDA UDI
- Regulation Number
- 878.4780 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
No
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
Yes
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
No
FDA UDI
Serial Number
Yes
FDA UDI
Expiration Date
No
FDA UDI
Manufacturing Date
No
FDA UDI
Category: Ophthalmic irrigation/aspiration pump
Trabectome I/A Console (110V) by Neomedix Corp. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Ophthalmic irrigation/aspiration pump.
- Trabectome I/A Console (100-240V) — Neomedix Corp. · Class II
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Neomedix Corp.
Sources (1)
- FDA UDI 22f4d2dd-06dc-4160-89b5-a8e97f4512d1 35 fields · synced Jun 8, 2026